Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-GP6, ACT-017 Vector   (CAT#: GTVCR-WQ284MR)

This product GTVCR-WQ284MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting GP6. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Humanized
RefSeq NM_001083899.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 51206
UniProt ID Q9HCN6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-GP6, ACT-017 Vector (GTVCR-WQ284MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1337MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL7R, GX-17 Vector Vector GX-17
GTVCR-WQ1346MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD52, GZ-402668 Vector Vector GZ-402668
GTVCR-WQ2155MR IVTScrip™ pT7-VEE-mRNA-Anti-TNF, OPRX-106 Vector Vector OPRX-106
GTVCR-WQ2350MR IVTScrip™ pSP6-VEE-mRNA-Anti-LAG3, aLAG367 Vector Vector aLAG367
GTVCR-WQ1686MR IVTScrip™ pSP6-VEE-mRNA-Anti-FN1, L19-IL-2 Vector Vector L19-IL-2
GTVCR-WQ2625MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, VEGF Trap Vector Vector VEGF Trap
GTVCR-WQ2353MR IVTScrip™ pSP6-VEE-mRNA-Anti-C5, REGN-3918 Vector Vector REGN-3918
GTVCR-WQ889MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL4-α, CD124 Vector Vector CD124
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW